We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
+17.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$74.4M
AUM Growth
-$7.7M
(-9.4%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-24.64%
Top 10 Holdings %
Top 10 Hldgs %
31.3%
Holding
122
New
27
Increased
23
Reduced
27
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$1.5M |
| 2 |
ServiceNow
NOW
|
+$1.34M |
| 3 |
DXC Technology
DXC
|
+$1.33M |
| 4 |
Microsoft
MSFT
|
+$1.31M |
| 5 |
Amazon
AMZN
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.44M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$2.3M |
| 3 |
Biogen
BIIB
|
+$2.15M |
| 4 |
WFT
Weatherford International plc
WFT
|
+$2.13M |
| 5 |
CSC
Computer Sciences
CSC
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.18% |
| 2 | Technology | 15.24% |
| 3 | Consumer Discretionary | 6.1% |
| 4 | Communication Services | 4.55% |
| 5 | Financials | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSOD
76
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $83K | 0.11% |
2,313
-14,199
| -86% | -$532K |
|
|
77
Biogen
BIIB
$29.8B
| $67K | 0.09% |
248
-8,115
| -97% | -$2.15M |
|
78
Peabody Energy
BTU
$2.65B
| $55K | 0.07% |
+2,244
| New | +$55.5K |
|
79
AbbVie
ABBV
$433B
| – | – |
-10,239
| Closed | -$667K |
|
80
Ardelyx
ARDX
$1.23B
| – | – |
-17,772
| Closed | -$225K |
|
81
Collegium Pharmaceutical
COLL
$1.15B
| – | – |
-12,216
| Closed | -$123K |
|
|
VISN
82
Vistance Networks Inc
VISN
$2.72B
| – | – |
-23,941
| Closed | -$999K |
|
83
Cirrus Logic
CRUS
$6.42B
| – | – |
-3,951
| Closed | -$240K |
|
84
Hain Celestial
HAIN
$45.5M
| – | – |
-20,737
| Closed | -$771K |
|
85
Herbalife
HLF
$1.32B
| – | – |
-18,984
| Closed | -$552K |
|
|
HOLX
86
DELISTED
Hologic
HOLX
| – | – |
-21,107
| Closed | -$898K |
|
87
Inogen
INGN
$182M
| – | – |
-1,171
| Closed | -$91K |
|
|
88
CALL
Jazz Pharmaceuticals
JAZZ
$15.8B
| – | – |
-3,400
| Closed | -$493K |
|
|
89
Jazz Pharmaceuticals
JAZZ
$15.8B
| – | – |
-15,857
| Closed | -$2.3M |
|
90
Eli Lilly
LLY
$1,000B
| – | – |
-13,895
| Closed | -$1.17M |
|
91
ArcelorMittal
MT
$54.2B
| – | – |
-3,848
| Closed | -$96K |
|
92
CALL
iShares S&P 100 ETF
OEF
$20.1B
| – | – |
-3,200
| Closed | -$938K |
|
|
93
PUT
iShares S&P 100 ETF
OEF
$20.1B
| – | – |
-8,800
| Closed | -$2.58M |
|
|
SAGE
94
DELISTED
Sage Therapeutics
SAGE
| – | – |
-1,572
| Closed | -$112K |
|
95
Starbucks
SBUX
$118B
| – | – |
-27,820
| Closed | -$1.62M |
|
|
SCHW
96
Charles Schwab
SCHW
$184B
| – | – |
-21,666
| Closed | -$884K |
|
97
SLB Ltd
SLB
$73.2B
| – | – |
-11,518
| Closed | -$900K |
|
98
Seagate
STX
$189B
| – | – |
-4,865
| Closed | -$223K |
|
99
Terex
TEX
$7.36B
| – | – |
-3,681
| Closed | -$116K |
|
100
Union Pacific
UNP
$173B
| – | – |
-6,279
| Closed | -$665K |
|
Similar funds
SWM
ACM
ECAU
SL
DII
FIM
EM
BHC
Partner Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, Partner Investment Management held 122 positions worth $74.4M, down 9.4% from $82.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Partner Investment Management withdrew a net $18.3M in Q2 2017, closing 36 positions and reducing 27 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Partner Investment Management opened a new position in McKesson worth $1.63M.
- Partner Investment Management's largest Q2 2017 buy was McKesson: 9,888 shares worth $1.63M.
- Partner Investment Management added most to Microsoft in Q2 2017, an estimated $1.31M increase.
- Partner Investment Management's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $2.44M.
- Partner Investment Management fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $2.3M.
- Partner Investment Management's ten largest holdings make up 31% of its $74.4M portfolio in Q2 2017.
- Partner Investment Management opened 27 new positions and closed 36 in Q2 2017.
- Partner Investment Management's portfolio value fell 9.4% quarter-over-quarter to $74.4M.
Based on Partner Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.